Filing Details

Accession Number:
0001209191-18-057412
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-06 16:34:29
Reporting Period:
2018-11-02
Accepted Time:
2018-11-06 16:34:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884624 Orthofix Medical Inc. OFIX Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1248184 T Luke Faulstick 3451 Plano Parkway
Lewisville TX 75056
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-11-02 3,500 $60.93 7,129 No 4 S Direct
Common Stock Disposition 2018-11-02 650 $61.72 6,479 No 4 S Direct
Common Stock Acquisiton 2018-11-02 4,300 $32.13 10,779 No 4 M Direct
Common Stock Disposition 2018-11-02 3,600 $60.93 7,179 No 4 S Direct
Common Stock Disposition 2018-11-02 700 $61.74 6,479 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-11-02 4,300 $0.00 4,300 $32.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,700 2024-09-17 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
  5. These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018.